Cargando…

Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma

BACKGROUND: PHGDH (Phosphoglycerate Dehydrogenase) is the first branch enzyme in the serine biosynthetic pathway and plays a vital role in several cancers. However, little is known about the clinical significance of PHGDH in endometrial cancer. METHODS: Clinicopathological data of endometrial cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, He, Kong, Weimin, Zhao, Xiaoling, Xie, Yunkai, Luo, Dan, Chen, Shuning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942409/ https://www.ncbi.nlm.nih.gov/pubmed/36803157 http://dx.doi.org/10.1186/s12920-023-01463-5

Ejemplares similares

Telomere-related genes as potential biomarkers to predict endometriosis and immune response: Development of a machine learning-based risk model
por: Zhang, He, et al.
Publicado: (2023)

Surgical Staging of Locally Advanced Cervical Cancer: Current Status and Research Progress
por: Zhang, He, et al.
Publicado: (2022)

Immune checkpoint inhibitors in cervical cancer: Current status and research progress
por: Xie, Yunkai, et al.
Publicado: (2022)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma
por: Li, Shaowen, et al.
Publicado: (2021)

Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer
por: Unterlass, Judith E., et al.
Publicado: (2016)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling
por: Chen, Chen, et al.
Publicado: (2022)

Comprehensive Analysis of RAPGEF2 for Predicting Prognosis and Immunotherapy Response in Patients with Hepatocellular Carcinoma
por: Wu, Qing, et al.
Publicado: (2022)

Prediction of Prognosis, Immunotherapy and Chemotherapy with an Immune-Related Risk Score Model for Endometrial Cancer
por: Wei, Wei, et al.
Publicado: (2023)

Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

Increased PHGDH expression promotes aberrant melanin accumulation
por: Mattaini, Katherine R., et al.
Publicado: (2019)

Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer
por: Jia, Xiao-qin, et al.
Publicado: (2016)

PHGDH as a mechanism for resistance in metabolically-driven cancers
por: Rathore, Richa, et al.
Publicado: (2020)

Multi-omics Analysis of the Role of PHGDH in Colon Cancer
por: Dai, Zhihui, et al.
Publicado: (2023)

Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma
por: Wu, Zhicheng, et al.
Publicado: (2022)

Comprehensive analysis of anoikis‐related lncRNAs for predicting prognosis and response of immunotherapy in hepatocellular carcinoma
por: Du, Sihao, et al.
Publicado: (2023)

Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
por: Liang, Deku, et al.
Publicado: (2021)

PHGDH supports liver ceramide synthesis and sustains lipid homeostasis
por: Kang, Yun Pyo, et al.
Publicado: (2020)

FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma
por: Wang, Zhe, et al.
Publicado: (2022)

Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
por: Shang, Taiyu, et al.
Publicado: (2023)

Development of a TGF-β signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma
por: Wu, Xin, et al.
Publicado: (2023)

Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC
por: Wang, Kaixuan, et al.
Publicado: (2023)

PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma
por: Wang, Kui, et al.
Publicado: (2023)

Renal UTX-PHGDH-serine axis regulates metabolic disorders in the kidney and liver
por: Chen, Hong, et al.
Publicado: (2022)

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma
por: Wu, Xin, et al.
Publicado: (2023)

Down regulating PHGDH affects the lactate production of sertoli cells in varicocele
por: Guo, Wen-bin, et al.
Publicado: (2020)

Dimerization of PHGDH via the catalytic unit is essential for its enzymatic function
por: Xu, Hanyu, et al.
Publicado: (2021)

ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC
por: Wang, Huihui, et al.
Publicado: (2023)

Correlation of Metabolic Factors with Endometrial Atypical Hyperplasia and Endometrial Cancer: Development and Assessment of a New Predictive Nomogram
por: Zhang, He, et al.
Publicado: (2021)

Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
por: Xu, Ziqian, et al.
Publicado: (2021)

Landscape of PCOS co-expression gene and its role in predicting prognosis and assisting immunotherapy in endometrial cancer
por: Zhang, Yun, et al.
Publicado: (2023)

A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma
por: Li, Qilin, et al.
Publicado: (2022)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022)

Functional genomics reveals serine synthesis is essential in PHGDH-amplified breast cancer
por: Possemato, Richard, et al.
Publicado: (2011)

Blood triglyceride levels are associated with DNA methylation at the serine metabolism gene PHGDH
por: Truong, Vinh, et al.
Publicado: (2017)

Structure–Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)
por: Spillier, Quentin, et al.
Publicado: (2020)

PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
por: Bi, Fangfang, et al.
Publicado: (2021)

Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma
por: Chen, Jianlin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rr1r5n3j5c6hnrmnuj3esi88le